As of 2026-10-02, the Relative Valuation of InMed Pharmaceuticals Inc (IN.TO) is (5.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 CAD, the upside of InMed Pharmaceuticals Inc based on Relative Valuation is -219.6%.
The range of the Relative Valuation is (4.62) - (5.09) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.4x - 3.7x | 3.0x |
| Forward P/E multiples | 3.3x - 5.0x | 4.2x |
| Fair Price | (4.62) - (5.09) | (5.01) |
| Upside | -210.3% - -221.6% | -219.6% |
| Date | P/E |